pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
RHYTHM · news · pharmadog
← back to RHYTHM
News mentioning RHYTHM
14
stories
5d
Abbott garners FDA nod for its TactiFlex catheter to treat AFib
fiercebiotech
10d
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
fda press
11d
An AI drug specialist zeroes in on rare forms of obesity
biopharma dive
11d
Superluminal secures $60M for Phase 1 of genetic obesity drug
endpoints
18d
Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
fda recalls
18d
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
19d
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
biospace
20d
Opinion: Whale songs: the sounds of love and loss as heard by an OB-GYN
stat
21d
Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
fda medwatch
24d
‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
fiercebiotech
Aug 5, 26
Opinion: Something is missing from movies about medical aid in dying
stat
Jul 30, 26
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
Jun 15, 26
Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
endpoints
May 18, 26
Opinion: ‘Patient autonomy’ has nothing to do with childhood vaccine policies
stat
